Results 231 to 240 of about 103,228 (328)

Endocannabinoid signaling in stress, nausea, and vomiting

Neurogastroenterology &Motility, Volume 37, Issue 3, March 2025.
Abstract Background Classical antiemetics that target the serotonin system may not be effective in treating certain nausea and vomiting conditions like cyclic vomiting syndrome (CVS) and cannabinoid hyperemesis syndrome (CHS). As a result, there is a need for better therapies to manage the symptoms of these disorders, including nausea, vomiting, and ...
Marieka V. DeVuono, Thangam Venkatesan, Cecilia J. Hillard   +2 more
wiley   +1 more source

Topical Neuropeptide Y for Ischemic Skin Wounds. [PDF]

Int J Mol Sci
Stangerup T, Gjerdrum LMR, Bzorek M, Andersen L, Heegaard AM, Jorgensen LN, Ågren MS.   +6 more
europepmc   +1 more source

Weight Loss‐Associated Remodeling of Adipose Tissue Immunometabolism

Obesity Reviews, EarlyView.
ABSTRACT Obesity is a multifactorial condition characterized by excessive adiposity and systemic chronic low‐grade inflammation. Recent literature reflects a growing appreciation for the complex interplay between metabolism and the immune system in the pathogenesis of obesity‐related health conditions.
Paulo José Basso, Alejandro Schcolnik‐Cabrera, Mengyi Zhu, Erin Strachan, Xavier Clemente‐Casares, Sue Tsai   +5 more
wiley   +1 more source

The Genetic Blueprint of Obesity: From Pathogenesis to Novel Therapies

Obesity Reviews, EarlyView.
ABSTRACT Obesity is a chronic metabolic disease characterized by disturbances in energy homeostasis, leading to excessive fat accumulation. The pathogenesis of the disease is shaped by a complex interplay of genetic, epigenetic, biological, psychological, and environmental factors.
Gašper Tonin, Stjepan Eržen, Zala Mlinarič, Dubravka Jurišić Eržen, Simon Horvat, Tanja Kunej, Jasna Klen   +6 more
wiley   +1 more source

Neuropeptide Y (18-36) is a competitive antagonist of neuropeptide Y in rat cardiac ventricular membranes.

, 1990
A. Balasubramaniam, Sulaiman Sheriff
openalex   +1 more source

Measurement of Neuropeptide Y in Aptamer-Modified Planar Electrodes. [PDF]

Electrochim Acta
López L, Martínez LM, Caicedo JR, Fernández-Vega L, Cunci L.   +4 more
europepmc   +1 more source

Contribution of Sympathetic Sensory Coupling to Craniofacial Nociception

Orthodontics &Craniofacial Research, EarlyView.
ABSTRACT Stress and anxiety are associated with increased pain intensity in temporomandibular disorders (TMDs) patients. It is possible that this association is due to a direct interaction between the sympathetic and sensory nervous systems. This narrative review examines evidence for a potential sympathetic sensory interaction in deep craniofacial ...
Brian Edwin Cairns
wiley   +1 more source

Neuropeptide Y stimulation of myosin light chain phosphorylation in cultured aortic smooth muscle cells.

, 1990
L. A. Lobaugh, Perry J. Blackshear
openalex   +1 more source

Bioelectronic block of stellate ganglia mitigates pacing-induced heterogeneous release of catecholamine and neuropeptide Y in the infarcted pig heart. [PDF]

J Physiol
Vrabec T, Bender S, Chan SA, Cha S, Haridas S, Hanna P, Ajijola OA, Shivkumar K, Smith C, Ardell JL.   +9 more
europepmc   +1 more source

Serum Biomarkers and Their Clinical Correlates in Traumatic Trigeminal Neuropathy: A Pilot Study

Oral Diseases, EarlyView.
ABSTRACT Objectives This study aims to investigate the serum biomarker levels in patients with painful post‐traumatic trigeminal neuropathy (PPTTN) and explore the associations between these biomarkers and the clinical and psychological characteristics of the patients. Materials and Methods A total of 32 patients with PPTTN were included.
Hye‐Kyoung Kim, Insoon Chang, Sung‐Hoon Lee   +2 more
wiley   +1 more source